Moleculin Biotech, Inc. SEC filings MBRX
Moleculin Biotech, Inc. has 838 filings in SEC EDGAR's recent list, going back to Dec 4, 2015. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Oct 15, 2026 | — |
| 424B5 | Prospectus supplement | Aug 21, 2026 | — |
| 424B5 | Prospectus supplement | Aug 3, 2026 | — |
| S-1/A | Amended registration statement | Jul 31, 2026 | — |
| S-1/A | Amended registration statement | Jul 30, 2026 | — |
| S-1 | Registration statement | Jul 29, 2026 | — |
| 424B3 | Prospectus | Apr 14, 2026 | — |
| S-3 | Shelf registration | Mar 27, 2026 | — |
| S-3 | Shelf registration | Dec 23, 2025 | — |
| 424B5 | Prospectus supplement | Dec 23, 2025 | — |
| 424B3 | Prospectus | Oct 3, 2025 | — |
| S-3 | Shelf registration | Sep 19, 2025 | — |
| S-8 | Employee stock plan registration | Sep 10, 2025 | — |
| 424B5 | Prospectus supplement | Jul 11, 2025 | — |
| 424B4 | Prospectus | Jun 23, 2025 | — |
| S-1/A | Amended registration statement | Jun 16, 2025 | — |
| S-1/A | Amended registration statement | Jun 11, 2025 | — |
| S-1/A | Amended registration statement | Jun 6, 2025 | — |
| S-1 | Registration statement | Jun 2, 2025 | — |
| S-1 | Registration statement | Mar 31, 2025 | — |
| 424B5 | Prospectus supplement | Feb 26, 2025 | — |
| S-1/A | Amended registration statement | Feb 11, 2025 | — |
| S-1/A | Amended registration statement | Feb 10, 2025 | — |
| S-1/A | Amended registration statement | Jan 29, 2025 | — |
| S-1 | Registration statement | Dec 13, 2024 | — |
| POS AM | Form pos am | Dec 3, 2024 | — |
| S-8 | Employee stock plan registration | Oct 25, 2024 | — |
| 424B3 | Prospectus | Aug 19, 2024 | — |
| 424B4 | Prospectus | Aug 16, 2024 | — |
| S-1/A | Amended registration statement | Aug 15, 2024 | — |
| S-1/A | Amended registration statement | Aug 15, 2024 | — |
| S-1/A | Amended registration statement | Jul 30, 2024 | — |
| S-1 | Registration statement | Jul 22, 2024 | — |
| S-3 | Shelf registration | Jun 7, 2024 | — |
| 424B3 | Prospectus | Feb 16, 2024 | — |
| S-1 | Registration statement | Feb 2, 2024 | — |
| 424B5 | Prospectus supplement | Dec 22, 2023 | — |
| S-8 | Employee stock plan registration | Jun 21, 2023 | — |
| S-8 | Employee stock plan registration | Jul 19, 2022 | — |
| 424B5 | Prospectus supplement | Jun 25, 2021 | — |
| 424B5 | Prospectus supplement | Jun 25, 2021 | — |
| S-3 | Shelf registration | May 28, 2021 | — |
| 424B5 | Prospectus supplement | Feb 4, 2021 | — |
| S-3MEF | Form s-3mef | Feb 2, 2021 | — |
| 424B5 | Prospectus supplement | Feb 2, 2021 | — |
| 424B5 | Prospectus supplement | Feb 2, 2021 | — |
| 424B5 | Prospectus supplement | Feb 2, 2021 | — |
| 424B5 | Prospectus supplement | Nov 12, 2020 | — |
| S-8 | Employee stock plan registration | Aug 21, 2020 | — |
| 424B5 | Prospectus supplement | Jul 17, 2020 | — |
| S-3/A | Filing | Mar 23, 2020 | — |
| 424B5 | Prospectus supplement | Feb 6, 2020 | — |
| 424B5 | Prospectus supplement | Feb 6, 2020 | — |
| S-3/A | Filing | Jan 17, 2020 | — |
| S-3 | Shelf registration | Jan 17, 2020 | — |
| S-3 | Shelf registration | Dec 23, 2019 | — |
| 424B5 | Prospectus supplement | Jul 24, 2019 | — |
| 424B5 | Prospectus supplement | Apr 24, 2019 | — |
| 424B5 | Prospectus supplement | Mar 29, 2019 | — |
| 424B5 | Prospectus supplement | Mar 26, 2019 | — |
| 424B3 | Prospectus | Oct 29, 2018 | — |
| S-1/A | Amended registration statement | Oct 25, 2018 | — |
| S-1 | Registration statement | Oct 15, 2018 | — |
| S-1 | Registration statement | Jul 12, 2018 | — |
| S-8 POS | Filing | Jun 27, 2018 | — |
| S-8 | Employee stock plan registration | Jun 25, 2018 | — |
| 424B5 | Prospectus supplement | Jun 21, 2018 | — |
| S-1/A | Amended registration statement | May 15, 2018 | — |
| S-1 | Registration statement | Apr 11, 2018 | — |
| 424B5 | Prospectus supplement | Feb 16, 2018 | — |
| POS AM | Filing | Oct 17, 2017 | — |
| 424B5 | Prospectus supplement | Sep 15, 2017 | — |
| S-3/A | Filing | Aug 11, 2017 | — |
| S-3 | Shelf registration | Jul 24, 2017 | — |
| 424B3 | Prospectus | Jun 30, 2017 | — |
| 424B3 | Prospectus | Mar 23, 2017 | — |
| 424B4 | Prospectus | Feb 10, 2017 | — |
| S-1MEF | Filing | Feb 9, 2017 | — |
| S-1/A | Amended registration statement | Feb 8, 2017 | — |
| S-1/A | Amended registration statement | Feb 7, 2017 | — |
| FWP | Free writing prospectus | Feb 2, 2017 | — |
| FWP | Free writing prospectus | Jan 23, 2017 | — |
| FWP | Free writing prospectus | Jan 23, 2017 | — |
| S-1/A | Amended registration statement | Jan 18, 2017 | — |
| S-1 | Registration statement | Dec 2, 2016 | — |
| S-8 | Employee stock plan registration | Jul 21, 2016 | — |
| 424B4 | Prospectus | May 3, 2016 | — |
| S-1MEF | Filing | May 2, 2016 | — |
| S-1/A | Amended registration statement | Apr 27, 2016 | — |
| S-1/A | Amended registration statement | Apr 15, 2016 | — |
| S-1/A | Amended registration statement | Mar 22, 2016 | — |
| FWP | Free writing prospectus | Feb 19, 2016 | — |
| S-1/A | Amended registration statement | Feb 16, 2016 | — |
| S-1 | Registration statement | Feb 1, 2016 | — |
Showing 94 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MBRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1659617
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.